From: Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach
Characteristics | Isolated DN (Group 1) n = 100 | NDRD ± DN (Group 2) n = 12 | P-value |
---|---|---|---|
Gender (male) | 55 (55%) | 10 (83.3%) | 0.06 |
Age (year) | 55.3 ± 11.5 | 58.8 ± 8.2 | 0.111 |
Body weight (kg) | 67.3 (56.3, 77.4) | 71.8 (67.4, 74) | 0.451 |
Height (cm) | 163.4 ± 8.1 | 165.3 ± 8.8 | 0.477 |
BMI (kg/m2) | 24.4 (22.2, 28.4) | 25.5 (24.2, 28.3) | 0.623 |
Duration of diabetes (yr) | 10 (4, 15.8) | 6 (3.5, 7.5) | 0.217 |
Diabetic retinopathy | |||
 PDR | 56 (56%) | 2 (16.7%) | 0.01 |
 ME | 15 (15%) | 2 (16.7%) | 1 |
 PRP | 54 (54%) | 2 (16.7%) | 0.029 |
 PC | 13 (13%) | 0 (0%) | 0.354 |
 IVI | 29 (29%) | 1 (8.3%) | 0.176 |
 VT | 8 (8%) | 0 (0%) | 0.596 |
HbA1c (%) | 7.1 (6.3, 9.1) | 7.8 (6.5, 9.6) | 0.437 |
Serum creatinine (mg/dL) | 2.9 (1.6, 4.7) | 3.7 (1.4, 10.8) | 0.316 |
eGFR (mL/min/1.73 m2) | 20.4 (10.9, 39.9) | 19.1 (4.3, 49.7) | 0.366 |
UPCR (1000 mg/g) | 9.1 (6.2, 12.5) | 7.2 (3.1, 11.9) | 0.214 |
Urinary red blood cells/HPF | 4 (4, 8) | 8 (4, 43) | 0.004 |
Urinary white blood cells/HPF | 1 (1, 4) | 1 (1, 4) | 0.69 |
Right kidney size (cm) | 11.6 ± 1.1 | 11.7 ± 1.2 | 0.785 |
Left kidney size (cm) | 11.5 ± 1.2 | 11.8 ± 1.0 | 0.481 |